| Galenica 2008 Revenue Up 6.9% At CHF2.7 Billion, Confirms 2008 Outlook - EasyBourse.com |
|
|
Vifor Pharma will push ahead with its strategy for more market focus and will expand its position as leader in the therapy areas of anaemia and nephrology. ... |